This study investigates pancreatic cancer. Researchers are exploring ways to detect this condition earlier, which could improve treatment outcomes.
The study will focus on identifying specific molecules that might indicate early changes in pancreatic cancer. By studying these molecules, researchers hope to find markers that can help in early detection.
- Who can participate: Adults 18 years and older who can provide informed consent are eligible. This includes individuals with localized pancreatic cancer or pancreatic cysts and those referred for pancreatic procedures.
- Study details: Participants will provide samples for analysis. Some will receive a placebo, an inactive substance that looks like the investigational medicine but does not contain any medicine.
How understandable was the trial content above?
Hard to understand
Easy to understand